EIF4A3-IN-1
EIF4A3-IN-1 is a selective eIF4A3 inhibitor (IC50: 0.26 μM; Kd: 0.043 μM) with cellular nonsense-mediated RNA decay (NMD) inhibitory activity. eIF4A3-IN-1 can specifically bind to the non-ATP binding site of eIF4A3. eIF4A3-IN-1 has anti-tumor and analgesic activities[1][2][3].
Product Specifications
CAS Number
2095486-67-0
UNSPSC
12352005
Target
Eukaryotic Initiation Factor (eIF)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/eif4a3-in-1.html
Purity
99.96
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
ClC(C=C1)=CC=C1[C@@H]2N(C(C3=CC=C(Br)C=C3)=O)CCN(C(C4=C(C)N(C5=CC=CC(C#N)=C5)N=C4)=O)C2
Molecular Formula
C29H23BrClN5O2
Molecular Weight
588.88
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FITC-Linked Polyclonal Antibody to Esophageal Cancer Related Gene 4 (ECRG4)
FITC-Linked Polyclonal Antibody to Esophageal Cancer Related Gene 4 (ECRG4)
FITC-Linked Polyclonal Antibody to Esophageal Cancer Related Gene 4 (ECRG4)